{"product_id":"emamiltd-bcg-matrix","title":"Emami Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnlock Strategic Clarity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eWant to know which Emami products are fueling growth and which are quietly eating cash? This Emami BCG Matrix preview shows the shape of the portfolio—now buy the full report to get quadrant-by-quadrant placement, data-backed recommendations and a ready-to-use Word report plus an Excel summary. Skip the guesswork; get strategic clarity fast and start reallocating resources where they’ll actually move the needle.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNavratna Cool Oil\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNavratna Cool Oil remains a high-growth summer-care and cooling-wellness leader in 2024, sustaining top brand salience and distribution reach across urban and rural markets. Emami continues to pour mass-media and outlet-level investment to defend share, making the brand cash-hungry yet category-defining. If momentum is sustained, Navratna can compound into a long-term growth engine for the company.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKesh King hair-fall range\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eKesh King hair-fall range is a Star in Emami's BCG matrix: an Ayurvedic anti–hair-fall problem-solver in a high-growth segment where Emami holds a leading perch. It needs aggressive product innovation and consumer education to outpace new entrants and maintain premium pricing. Marketing spends are high but velocity and distribution remain strong. With continued scale and margin control, the range can transition into a cash cow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZandu OTC immunity \u0026amp; digestives\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZandu’s herbal OTC portfolio (Chyawanprash, Pancharishta, etc.) capitalizes on the ongoing Ayurveda uptrend, showing robust growth and strong brand recall under Emami. The franchise is a Star today but needs sustained activation in pharmacies and e‑commerce to lock market share and convert into a cash cow. Continued investment in distribution and digital campaigns is critical for long-term category leadership.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrickly-heat powders portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePrickly-heat powders are seasonal but expanding; the cooling-powder category grew ~8% in 2024 and Emami’s brands sit near the top with an estimated ~25% market share. Distribution width and summer activations soak up investment, yet payback is rapid as ~60–70% of annual volumes occur in peak months (Apr–Jun). Keeping share intact makes this a durable annuity for Emami.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCategory growth 2024: ~8%\u003c\/li\u003e\n\u003cli\u003eEmami share: ~25%\u003c\/li\u003e\n\u003cli\u003ePeak months sales: ~60–70% (Apr–Jun)\u003c\/li\u003e\n\u003cli\u003eHigh upfront activation; fast payback\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eE‑commerce first Ayurvedic SKUs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eZandu\/Emami digital SKUs are scaling across marketplaces and D2C, tapping an Indian online FMCG penetration of ~10–12% in 2024 and segment growth for Ayurvedic\/NPC estimated ~20–25% YoY; share remains early, under 5% in many subcategories.\u003c\/p\u003e\n\u003cp\u003eSuccess requires high-quality content, review velocity and 3–4 month NPD cycles; the right bets can seed the next flagship lines and drive double‑digit digital revenue contribution within 2–3 years.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003emarketplace + D2C scale\u003c\/li\u003e\n\u003cli\u003eonline FMCG ~10–12% (2024)\u003c\/li\u003e\n\u003cli\u003eAyurvedic\/NPC growth ~20–25% YoY\u003c\/li\u003e\n\u003cli\u003eneed content, reviews, fast NPD\u003c\/li\u003e\n\u003cli\u003epotential for next flagship lines\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOTC cooling powders drive growth; heavy marketing \u0026amp; distribution spend to defend share\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNavratna, Kesh King and Zandu OTC are Stars for Emami in 2024, driving high growth but requiring heavy marketing and distribution spend to defend share and scale margins. Cooling powders grew ~8% (2024) with Emami ~25% share and 60–70% seasonality; online FMCG penetration ~10–12% and Ayurvedic\/NPC digital growth ~20–25% YoY.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003cth\u003eCategory growth 2024\u003c\/th\u003e\n\u003cth\u003eEmami share\u003c\/th\u003e\n\u003cth\u003ePeak sales\u003c\/th\u003e\n\u003cth\u003eOnline notes\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNavratna\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003eHigh spend\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCooling powders\u003c\/td\u003e\n\u003ctd\u003e~8%\u003c\/td\u003e\n\u003ctd\u003e~25%\u003c\/td\u003e\n\u003ctd\u003e60–70% (Apr–Jun)\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital\/Ayurvedic\u003c\/td\u003e\n\u003ctd\u003e20–25% YoY\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;5%\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003eOnline FMCG 10–12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG analysis of Emami’s portfolio — Stars, Cash Cows, Question Marks, Dogs with investment, hold\/divest guidance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page Emami BCG Matrix placing each brand in a quadrant for instant strategic clarity\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBoroPlus antiseptic cream\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBoroPlus antiseptic cream sits as a mature, trusted cash cow for Emami: classic high-share, low-growth with wide distribution in 60+ countries and deep retail penetration across India. Marketing can be efficient as pricing and margins remain steady, generating surplus cash to fund newer growth plays. Emami continues to milk the brand while modernizing formats and packs to sustain relevance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZandu Balm \/ Ultra Power Balm\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZandu Balm \/ Ultra Power Balm is an iconic pain balm with entrenched everyday usage and pharmacy dominance; Emami’s brands remain category leaders. Category growth is modest, low single digits in 2024, while brand share stays stout, delivering predictable margins and cash flow with minimal incremental marketing spend. Priority: protect core SKUs and optimize trade terms to sustain cash generation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHimani Fast Relief\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHimani Fast Relief is a pain-relief rub\/spray with stable consumer demand and strong brand recall in the mature topical analgesic lane, where growth is incremental rather than exponential. Its established distribution and predictable throughput deliver solid gross margins and steady cash generation. Management uses Fast Relief as a low-risk funding base to finance higher-beta product launches and marketing for growth segments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNavratna Cool Talc\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eNavratna Cool Talc sits on a large, established consumer base but faces slower category momentum, making it a classic cash cow within Emami’s BCG matrix. Advertising can remain focused and seasonal to protect share while minimizing spend; the brand continues to throw off steady cash despite limited growth upside. Prioritize assortment optimisation and tight distribution control to sustain margins and ROI.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLarge base\u003c\/li\u003e\n\u003cli\u003eSlower category momentum\u003c\/li\u003e\n\u003cli\u003eSeasonal, focused advertising\u003c\/li\u003e\n\u003cli\u003eHigh cash generation, low growth\u003c\/li\u003e\n\u003cli\u003eOptimize assortment \u0026amp; tighten distribution\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthy \u0026amp; Tasty edible oils\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003ch3\u003eHealthy \u0026amp; Tasty edible oils\u003c\/h3\u003eScale and strong regional distribution give this Cash Cow steady shelf presence; the category is mature and increasingly price-led in 2024. Working-capital intensity remains high due to inventory and commodity cycles, but at steady volumes the brand is cash generative. Low incremental A\u0026amp;P needs mean efficiency improvements flow straight to free cash.\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eScale \u0026amp; regional strength\u003c\/li\u003e\n\u003cli\u003eMature, price-led market (2024)\u003c\/li\u003e\n\u003cli\u003eWorking-capital heavy but cash generative\u003c\/li\u003e\n\u003cli\u003eLow incremental A\u0026amp;P; efficiency lifts free cash\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProtect share, optimize assortment, tighten trade, defend steady-margin cash engines\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBoroPlus, Zandu\/Ultra Power Balm, Himani Fast Relief, Navratna Cool Talc and Healthy \u0026amp; Tasty oils are mature, high-share, low-growth cash cows for Emami, generating steady margins and surplus cash. Distribution is wide (60+ countries for BoroPlus) and category growth is low single-digit in 2024. Focus: protect share, optimize assortment, tighten trade terms and channel efficiency.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003cth\u003e2024 growth\u003c\/th\u003e\n\u003cth\u003eDistribution\u003c\/th\u003e\n\u003cth\u003eCash profile\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eBoroPlus\u003c\/td\u003e\n\u003ctd\u003eLow single-digit\u003c\/td\u003e\n\u003ctd\u003e60+ countries\u003c\/td\u003e\n\u003ctd\u003eHigh, steady\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eZandu\/Ultra\u003c\/td\u003e\n\u003ctd\u003eLow single-digit\u003c\/td\u003e\n\u003ctd\u003ePharmacy\/retail\u003c\/td\u003e\n\u003ctd\u003ePredictable\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Transparency, Always\u003c\/span\u003e\u003cbr\u003eEmami BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the exact Emami BCG Matrix report you'll receive after purchase. No watermarks or demo notes—just the fully formatted, ready-to-use analysis crafted for strategic clarity. Once bought, the full document is sent to your inbox and unlocked for editing, printing, or presenting. No surprises, no extra revisions—just plug it into your planning and go.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eD\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eogs\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFair \u0026amp; Handsome\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFair \u0026amp; Handsome, launched in 2007, sits in a shrinking fairness-cream category under growing social pushback and regulatory scrutiny over skin-lightening claims and safety concerns flagged by international health agencies. Low growth and reported declining market relevance have turned it into a cash-trap for Emami, with brand strategy now needing radical repositioning or phased exit. Either reposition toward grooming\/skin-health or exit gracefully to stem margin erosion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHE deodorants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHE deodorants sit in the Dogs quadrant: a crowded, promo-driven aisle with fickle loyalty and high acquisition churn.\u003c\/p\u003e\n\u003cp\u003eDistribution costs erode margins and brand holds a small share versus category leaders, making turnarounds costly and rarely durable.\u003c\/p\u003e\n\u003cp\u003eBest action is SKU rationalization or divestment to stop margin bleed and redeploy capital to higher-growth segments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBio‑diesel vertical\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNo standalone public disclosures exist for an Emami biodiesel vertical as of 2024, limiting granular financial analysis; industry risks include policy swings (biofuel mandates and subsidy changes) and feedstock price volatility that compress margins. Limited brand edge and capital tied up with muted returns align with low-growth, low-share BCG Dog dynamics; management should consider exit or repurposing capacity to higher-return uses.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLegacy real‑estate projects\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eLegacy real‑estate projects are cyclical and non‑core to Emami’s FMCG focus, tying up cash as inventory churn slows and reducing capital available for core growth; with limited competitive moat versus specialist developers, these assets drag margins and ROIC.\u003c\/p\u003e\n\u003cp\u003ePrune, partner, or wind down: consider JV\/exit to free capital, transfer inventory risk, and redeploy proceeds into high‑margin FMCG categories where Emami has stronger scale and brand moat.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTag: cyclical\u003c\/li\u003e\n\u003cli\u003eTag: non‑core\u003c\/li\u003e\n\u003cli\u003eTag: inventory drag\u003c\/li\u003e\n\u003cli\u003eTag: limited moat\u003c\/li\u003e\n\u003cli\u003eTag: prune\/partner\/wind‑down\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNiche international cosmetics (e.g., Creme 21)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eNiche international cosmetics such as Creme 21 sit in Emami’s Dogs quadrant: limited scale in core Indian markets and a heavy localization lift required; marketing spend has not converted into meaningful market share and the SKUs operate at best near break-even. Recheck strategic fit or consider spinning off to cut ongoing marketing burn and redeploy capital to higher-growth brands.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLimited scale\u003c\/li\u003e\n\u003cli\u003eHigh localization costs\u003c\/li\u003e\n\u003cli\u003eMarketing burn ≠ share\u003c\/li\u003e\n\u003cli\u003eBreak-even at best\u003c\/li\u003e\n\u003cli\u003eRecheck fit \/ spin off\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrune low-growth SKUs; divest non-core assets to stop cash bleed, free capital\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMultiple Emami Dogs (Fair \u0026amp; Handsome, HE deodorants, biodiesel pilot, legacy real estate, Creme 21) show low growth and low share, tying up capital and eroding margins; repositioning or exit recommended. Prune SKUs, seek JV\/divestment, or repurpose capacity into core FMCG where Emami has scale. Prioritize SKU rationalization to stop cash bleed.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eAsset\u003c\/th\u003e\n\u003cth\u003eStatus (2024)\u003c\/th\u003e\n\u003cth\u003eAction\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFair \u0026amp; Handsome\u003c\/td\u003e\n\u003ctd\u003eShrinking category\u003c\/td\u003e\n\u003ctd\u003eReposition\/exit\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHE deodorants\u003c\/td\u003e\n\u003ctd\u003eLow share\u003c\/td\u003e\n\u003ctd\u003eRationalize\/divest\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eQ\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euestion Marks\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eThe Man Company stake \/ men’s grooming\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEmami’s 60% stake in The Man Company places it in a Question Mark: the men’s grooming category is a high-growth, premium-potential segment showing double-digit expansion, yet Emami’s revenue contribution from this stake remains modest versus core brands. Success requires sharper positioning and omni-channel muscle, backing a few hero SKUs or consolidating the portfolio. Move fast to scale or reallocate capital if growth\/market share targets aren’t met.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBoroPlus premium skincare formats\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBoroPlus serums, gels and naturals target younger shoppers—segments that helped the global skincare market reach about $180bn in 2024—offering a clear growth runway despite BoroPlus’s current low share and early traction. Trial will require influencer seeding plus dermatology trust cues to convert sampling into repeat purchases. Monitor repeat rates closely; double-down if 3‑month repeat exceeds brand baseline. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZandu nutraceuticals D2C\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZandu Nutraceuticals D2C sees gummies, shots and effervescents gaining strong online traction, driven by convenience and repeat formats. Customer acquisition costs remain high today with lifetime value still uncertain across cohorts. If cohort retention and LTV stabilize to cover CAC, the business can flip to a Star; if not, management should cut the tail. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEmami 7 Oils in One\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eEmami 7 Oils in One is a Question Mark: it competes in a tough hair-oil core where incumbents dominate and the brand shows platform promise but continues to lag on share. The franchise needs crisp benefit proof, stronger salon and dermatologist advocacy, and targeted product claims to convert trial into loyal users. Invest selectively by region where distribution and marketing ROI are demonstrably positive.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCompetitive position: niche challenger\u003c\/li\u003e\n\u003cli\u003ePriority: benefit proof \u0026amp; professional advocacy\u003c\/li\u003e\n\u003cli\u003eInvestment: selective, region-focused\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSEA\/MENA expansion of core brands\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSEA (~680 million consumers) and MENA (~500 million consumers) offer a large whitespace for Emami, but low current international share and fragmented distribution plus differing regulations constrain rapid scaling; market growth runways average mid-single digits regionally, making targeted country bets sensible. Test-and-scale in 2–3 focused markets, and exit where unit economics, CAC or margin thresholds fail to clear.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\u003c\/ul\u003e\n\u003cli\u003eLow intl share today; high whitespace\u003c\/li\u003e\n\u003cli\u003eDistribution and regulation are key hurdles\u003c\/li\u003e\n\u003cli\u003eTargeted test-and-scale (2–3 countries)\u003c\/li\u003e\n\u003cli\u003ePull back if unit economics don’t meet thresholds\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScale question-marks fast: focus hero SKUs, omni-channel, derm\/salon advocacy, test 2-3 intl\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEmami Question Marks need fast scale or capital reallocation; prioritize hero SKUs, omni-channel, dermatologist\/salon advocacy, and test-and-scale in 2–3 intl markets with strict unit-economics gates.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003cth\u003eCategory\u003c\/th\u003e\n\u003cth\u003eStatus\u003c\/th\u003e\n\u003cth\u003eKey metric (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eThe Man Company\u003c\/td\u003e\n\u003ctd\u003eMen’s grooming\u003c\/td\u003e\n\u003ctd\u003eQuestion Mark\u003c\/td\u003e\n\u003ctd\u003e60% stake\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBoroPlus\u003c\/td\u003e\n\u003ctd\u003eSkincare\u003c\/td\u003e\n\u003ctd\u003eQuestion Mark\u003c\/td\u003e\n\u003ctd\u003eGlobal skincare ~$180bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eZandu D2C\u003c\/td\u003e\n\u003ctd\u003eNutraceuticals\u003c\/td\u003e\n\u003ctd\u003eQuestion Mark\u003c\/td\u003e\n\u003ctd\u003eHigh CAC, LTV uncertain\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7 Oils in One\u003c\/td\u003e\n\u003ctd\u003eHair oil\u003c\/td\u003e\n\u003ctd\u003eQuestion Mark\u003c\/td\u003e\n\u003ctd\u003eIncumbent-dominated\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntl\u003c\/td\u003e\n\u003ctd\u003eSEA \/ MENA\u003c\/td\u003e\n\u003ctd\u003eOpportunity\u003c\/td\u003e\n\u003ctd\u003eSEA 680m; MENA 500m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"PESTEL Analysis","offers":[{"title":"Default Title","offer_id":58098083692892,"sku":"emamiltd-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0938\/8127\/0620\/files\/emamiltd-bcg-matrix.png?v=1781793140","url":"https:\/\/pestel-analysis.com\/products\/emamiltd-bcg-matrix","provider":"PESTEL ANALYSIS","version":"1.0","type":"link"}